Evidence map›Paper›PMID 31447794›Full record

ArticleFrontiers in microbiology2019

The Emergence of Rare Clinical

Husam Salah, Michaela Lackner, Jos Houbraken, Bart Theelen, Cornelia Lass-Flörl, Teun Boekhout, Muna Almaslamani, Saad J Taj-Aldeen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Identification ofFrontiers in veterinary science · 2025
    Article
  5. Article
  6. A case ofHeliyon · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. First Report of Azole-ResistantJournal of fungi (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Studies in mycology · 2021
    Review
  18. Article
  19. Article
  20. Toxicology reports · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Husam SalahDivision of Microbiology, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Michaela LacknerDivision of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
Jos HoubrakenApplied and Industrial Mycology, Westerdijk Fungal Biodiversity Institute, Utrecht, Netherlands.
Bart TheelenYeast Research, Westerdijk Fungal Biodiversity Institute, Utrecht, Netherlands.
Cornelia Lass-FlörlDivision of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
Teun BoekhoutYeast Research, Westerdijk Fungal Biodiversity Institute, Utrecht, Netherlands.
Muna AlmaslamaniInstitute of Biodiversity and Ecosystem Dynamics (IBED), University of Amsterdam, Netherlands.
Saad J Taj-AldeenDivision of Microbiology, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Westerdijk Fungal Biodiversity Institute · NLUniversität Innsbruck · ATUniversity of Amsterdam · NLHamad Medical Corporation · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antifungal susceptibilityaspergillosisMiddle Eastmolecular identificationQatar

Identifiers

PMID31447794
PMCPMC6697061
OpenAlexW2958739793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.